Posts by: Iqra Mumal

Iqra Mumal

August 6, 2018

Long-term Use of Cholesterol-lowering Medications May Benefit Some Prostate Cancer Patients, Trial Shows

News

Long-term treatment with atorvastatin, a cholesterol-lowering medicine, may reduce the proliferation of prostate cancer cells in some patients, a randomized trial suggests. Results from the trial were published in the ... Read more

August 2, 2018

Study Uncovers How Genetic Mutation Causes Aggressive Forms of Prostate Cancer

News

A type of mutation in a single nucleotide called rs11672691 plays a role in the development of aggressive prostate cancer by increasing the levels of two genes, PCAT19 and CEACAM21, a ... Read more

July 26, 2018

Long-term ADT Use Can Diminish Tumors’ Visibility on Scans, Study Reports

News

Long-term use of androgen deprivation therapy (ADT) can make prostate cancer lesions difficult or impossible to see on some imaging scans, even in tumors that continue to grow, a new study ... Read more

July 11, 2018

Artificial Intelligence Could Shed Light on Development, Diagnosis, and Treatment of Prostate Cancer

News

Using artificial intelligence to identify genetic patterns in prostate cancer tissue could help shed light on how tumors develops and improve clinical diagnosis and treatment, a study reports. The approach uses ... Read more

March 21, 2018March 21, 2018

Higher Doses of Radiation Therapy Don’t Increase Survival in Prostate Cancer Patients, Phase 3 Trial Finds

News

While higher doses of radiation therapy in patients with intermediate-risk prostate cancer lower the need for secondary therapies, the approach does not improve overall survival, results from a Phase 3 ... Read more

February 23, 2018February 23, 2018

Adding Zytiga and Prednisone to Regimen Is Effective in Treating High-Risk Prostate Cancer, Study Finds

News

Adding Zytiga (abiraterone acetate) plus prednisone to a regimen of radiotherapy and androgen deprivation therapy is effective in treating patients with high-risk prostate cancer, a Phase 2 clinical trial ... Read more

February 7, 2018February 7, 2018

Study Links High Receptor Levels to Reduced Survival in Diabetic Prostate Cancer Patients

News

High levels of the androgen receptor protein may play a role in the lower survival rate of men with both type 2 diabetes and prostate cancer, a study reports. ... Read more

January 8, 2018January 8, 2018

Side Effects of Prostate Cancer Therapy Cause High Emotional Distress, Study Confirms

News

Urinary, sexual, and bowel dysfunction, which are side effects of prostate cancer treatment, can cause elevated emotional distress for at least two years post-treatment, a new study shows. The study, ... Read more

December 15, 2017December 15, 2017

Xtandi Does Not Increase Seizure Rates in At-Risk mCRPC Patients, Study Finds

News

A safety study that looked at the treatment of metastatic castration-resistant prostate cancer (mCRPC) patients with Xtandi (enzalutamide) found that the therapy does not increase seizure rates for those who ... Read more

September 20, 2017

INO-5150 Triggers Immune Responses, Delays Progression of Prostate Cancer That Returns, Trial Shows

News

The immunotherapy INO-5150 has shown promise as a treatment for prostate cancer that returns after surgery, according to a Phase 1b clinical trial. Inovio Pharmaceuticals’ cancer vaccine generated immune responses ... Read more